Advances in targeting cyclic nucleotide phosphodiesterases

DH Maurice, H Ke, F Ahmad, Y Wang… - Nature reviews Drug …, 2014 - nature.com
Cyclic nucleotide phosphodiesterases (PDEs) catalyse the hydrolysis of cyclic AMP and
cyclic GMP, thereby regulating the intracellular concentrations of these cyclic nucleotides …

Vector platforms for gene therapy of inherited retinopathies

I Trapani, A Puppo, A Auricchio - Progress in retinal and eye research, 2014 - Elsevier
Inherited retinopathies (IR) are common untreatable blinding conditions. Most of them are
inherited as monogenic disorders, due to mutations in genes expressed in retinal …

Lighting a candle in the dark: advances in genetics and gene therapy of recessive retinal dystrophies

AI den Hollander, A Black, J Bennett… - The Journal of …, 2010 - Am Soc Clin Investig
Nonsyndromic recessive retinal dystrophies cause severe visual impairment due to the
death of photoreceptor and retinal pigment epithelium cells. These diseases until recently …

Cyclic nucleotide phosphodiesterases: important signaling modulators and therapeutic targets

F Ahmad, T Murata, K Shimizu, E Degerman… - Oral …, 2015 - Wiley Online Library
By catalyzing hydrolysis of cyclic adenosine monophosphate (cAMP) and cyclic guanosine
monophosphate (cGMP), cyclic nucleotide phosphodiesterases are critical regulators of their …

Long-term safety and efficacy of human-induced pluripotent stem cell (iPS) grafts in a preclinical model of retinitis pigmentosa

Y Li, YT Tsai, CW Hsu, D Erol, J Yang, WH Wu… - Molecular …, 2012 - Springer
Abstract The US Food and Drug Administration recently approved phase I/II clinical trials for
embryonic stem (ES) cell-based retinal pigmented epithelium (RPE) transplantation, but this …

CRISPR repair reveals causative mutation in a preclinical model of retinitis pigmentosa

WH Wu, YT Tsai, S Justus, TT Lee, L Zhang, CS Lin… - Molecular Therapy, 2016 - cell.com
Massive parallel sequencing enables identification of numerous genetic variants in mutant
organisms, but determining pathogenicity of any one mutation can be daunting. The most …

Advances in gene therapy for diseases of the eye

L Petit, H Khanna, C Punzo - Human gene therapy, 2016 - liebertpub.com
Over the last few years, huge progress has been made with regard to the understanding of
molecular mechanisms underlying the pathogenesis of neurodegenerative diseases of the …

Gene therapy in inherited retinal degenerative diseases, a review

VKL Takahashi, JT Takiuti, R Jauregui… - Ophthalmic …, 2018 - Taylor & Francis
Hereditary diseases of the retina represent a group of diseases with several heterogeneous
mutations that have the common end result of progressive photoreceptor death leading to …

Reprogramming metabolism by targeting sirtuin 6 attenuates retinal degeneration

L Zhang, J Du, S Justus, CW Hsu… - The Journal of …, 2016 - Am Soc Clin Investig
Retinitis pigmentosa (RP) encompasses a diverse group of Mendelian disorders leading to
progressive degeneration of rods and then cones. For reasons that remain unclear …

The PDE6 mutation in the rd10 retinal degeneration mouse model causes protein mislocalization and instability and promotes cell death through increased ion influx

T Wang, J Reingruber, ML Woodruff… - Journal of Biological …, 2018 - ASBMB
The retinal degeneration model rd10 contains a missense mutation of the catalytic PDE6 β
subunit, which hydrolyzes cGMP in response to light. This model produces cell death more …